lobbying_activities: 2057949

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2057949 c4dcf8d3-aed9-4e88-a98d-2dd97873c4c3 Q4 ADVANCED POLICY CONSULTING, LLC 401103524 AMGEN USA INC. 2017 fourth_quarter HCR Market based solutions to bring down the cost of drug prices. Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Issuing new codes in a timely fashion for the Medicare End-Stage Renal Disease (ESRD) Program. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Treasury, Dept of 50000   0 0 2018-01-04T09:17:39.753000-05:00